| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Emily Rose, Shanquan Chen, Concha Turrion, Christopher Jenkins, Rudolf N Cardinal, Emilio Fernandez-Ege. Causes of death in clozapine-treated patients in a catchment area: a 10-year retrospective case-control study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 36. 2021-08-10. PMID:32546415. |
here, we aimed to assess a decade of causes of deaths in a catchment area in patients with schizophrenia chronically treated with clozapine and compared them to a clozapine-treated control cohort. |
2021-08-10 |
2023-08-13 |
Not clear |
| Mikiko Ishibashi, Kentaro Matsui, Masahiko Kawano, Hidehiro Oshibuchi, Jun Ishigooka, Katsuji Nishimura, Ken Inad. Clinical Factors Associated with New-Onset Glucose Intolerance among Patients with Schizophrenia during Clozapine Treatment: All-Case Surveillance in Japan. The Tohoku journal of experimental medicine. vol 252. issue 2. 2021-08-09. PMID:33055431. |
clinical factors associated with new-onset glucose intolerance among patients with schizophrenia during clozapine treatment: all-case surveillance in japan. |
2021-08-09 |
2023-08-13 |
Not clear |
| Mikiko Ishibashi, Kentaro Matsui, Masahiko Kawano, Hidehiro Oshibuchi, Jun Ishigooka, Katsuji Nishimura, Ken Inad. Clinical Factors Associated with New-Onset Glucose Intolerance among Patients with Schizophrenia during Clozapine Treatment: All-Case Surveillance in Japan. The Tohoku journal of experimental medicine. vol 252. issue 2. 2021-08-09. PMID:33055431. |
clozapine (clz), an antipsychotic with a unique mechanism of action, is known to be superior to any other antipsychotic for schizophrenia. |
2021-08-09 |
2023-08-13 |
Not clear |
| b' El\\xc3\\xa7in \\xc3\\x96z\\xc3\\xa7elik Ero\\xc4\\x9flu, Ayg\\xc3\\xbcn Ertu\\xc4\\x9frul, Kader Karl\\xc4\\xb1 O\\xc4\\x9fuz, Sevilay Karahan, M K\\xc3\\xa2z\\xc4\\xb1m Yaz\\xc4\\xb1c\\xc4\\xb. Effect of Clozapine on Proton Magnetic Resonance Spectroscopy Findings in Hippocampus. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 31. issue 3. 2021-08-06. PMID:32978951.' |
the purpose of this study was to investigate the effect of clozapine on proton magnetic resonance spectroscopy (1h-mrs) findings in hippocampus in patients with schizophrenia. |
2021-08-06 |
2023-08-13 |
Not clear |
| Ibrahim A Akkouh, Hana Hribkova, Marta Grabiec, Eva Budinska, Attila Szabo, Tomas Kasparek, Ole A Andreassen, Yuh-Man Sun, Srdjan Djurovi. Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response. Schizophrenia bulletin. 2021-08-06. PMID:34357384. |
derivation and molecular characterization of a morphological subpopulation of human ipsc astrocytes reveal a potential role in schizophrenia and clozapine response. |
2021-08-06 |
2023-08-13 |
human |
| Ibrahim A Akkouh, Hana Hribkova, Marta Grabiec, Eva Budinska, Attila Szabo, Tomas Kasparek, Ole A Andreassen, Yuh-Man Sun, Srdjan Djurovi. Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response. Schizophrenia bulletin. 2021-08-06. PMID:34357384. |
we further found reduced levels of both glutamate and the nmda receptor coagonist d-serine in subtype astrocytes derived from schizophrenia patients, and that exposure to clozapine only rescued this deficiency in cells from clozapine responders, providing further evidence that d-serine in particular, and nmda receptor-mediated glutamatergic neurotransmission in general, could play an important role in disease pathophysiology and clozapine action. |
2021-08-06 |
2023-08-13 |
human |
| Theodore R Zarzar, Joseph B Williams, Megan E Pruette, Brian B Sheitma. A Legal Right to Clozapine Therapy for Incarcerated Individuals With Treatment-Resistant Schizophrenia. Psychiatric services (Washington, D.C.). vol 72. issue 4. 2021-08-03. PMID:33593106. |
a legal right to clozapine therapy for incarcerated individuals with treatment-resistant schizophrenia. |
2021-08-03 |
2023-08-13 |
Not clear |
| Theodore R Zarzar, Joseph B Williams, Megan E Pruette, Brian B Sheitma. A Legal Right to Clozapine Therapy for Incarcerated Individuals With Treatment-Resistant Schizophrenia. Psychiatric services (Washington, D.C.). vol 72. issue 4. 2021-08-03. PMID:33593106. |
however, incarcerated patients with treatment-resistant schizophrenia (trs) often are not offered clozapine, the only medication for this debilitating illness approved by the u.s. food and drug administration. |
2021-08-03 |
2023-08-13 |
Not clear |
| Sandeep Grover, Anish Shouan, Subho Chakrabarti, Swapnajeet Sahoo, Aseem Mehr. Comparative study of effectiveness of augmentation with ECT in clozapine resistant schizophrenia (CRS) and non-clozapine resistant schizophrenia (Non-CRS). Nordic journal of psychiatry. vol 75. issue 6. 2021-08-03. PMID:33630681. |
comparative study of effectiveness of augmentation with ect in clozapine resistant schizophrenia (crs) and non-clozapine resistant schizophrenia (non-crs). |
2021-08-03 |
2023-08-13 |
Not clear |
| Sandeep Grover, Anish Shouan, Subho Chakrabarti, Swapnajeet Sahoo, Aseem Mehr. Comparative study of effectiveness of augmentation with ECT in clozapine resistant schizophrenia (CRS) and non-clozapine resistant schizophrenia (Non-CRS). Nordic journal of psychiatry. vol 75. issue 6. 2021-08-03. PMID:33630681. |
there is limited evidence for different treatment strategies in patients with clozapine resistant schizophrenia (crs). |
2021-08-03 |
2023-08-13 |
Not clear |
| Anna Maria Szota, Izabela Radajewska, Aleksander Stanisław Araszkiewic. Atypical Neuroleptic Malignant Syndrome: Case Reports and Diagnostic Challenges. Journal of psychoactive drugs. 2021-08-03. PMID:34340640. |
atypical neuroleptic malignant syndrome was found to develop mainly in male patients suffering from schizophrenia (14 cases) and bipolar disorder (2), and was induced by clozapine (6 cases), olanzapine (5 cases), aripiprazole and quetiapine (4 cases). |
2021-08-03 |
2023-08-13 |
Not clear |
| Francesca Martini, Marco Spangaro, Mariachiara Buonocore, Margherita Bechi, Federica Cocchi, Carmelo Guglielmino, Laura Bianchi, Jacopo Sapienza, Giulia Agostoni, Antonella Mastromatteo, Marta Bosia, Roberto Cavallar. Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex. Psychiatry research. vol 297. 2021-07-30. PMID:33440269. |
clozapine tolerability in treatment resistant schizophrenia: exploring the role of sex. |
2021-07-30 |
2023-08-13 |
Not clear |
| Francesca Martini, Marco Spangaro, Mariachiara Buonocore, Margherita Bechi, Federica Cocchi, Carmelo Guglielmino, Laura Bianchi, Jacopo Sapienza, Giulia Agostoni, Antonella Mastromatteo, Marta Bosia, Roberto Cavallar. Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex. Psychiatry research. vol 297. 2021-07-30. PMID:33440269. |
clozapine is the only evidence-based drug indicated for treatment resistant schizophrenia but it is largely underprescribed, partially due to its life-threatening adverse effects (aes). |
2021-07-30 |
2023-08-13 |
Not clear |
| Sandeep Grover, Chandrima Naskar, Swapnajeet Sahoo, Aseem Mehra, Subho Chakrabart. Starting clozapine in patients with schizophrenia during the ongoing pandemic. Schizophrenia research. 2021-07-29. PMID:34303594. |
starting clozapine in patients with schizophrenia during the ongoing pandemic. |
2021-07-29 |
2023-08-13 |
Not clear |
| Jennifer Erley, Sarah Goldsborough, Amy VandenBerg, Alexandra Aud. Loxapine in patient with clozapine-resistant psychosis. The mental health clinician. vol 11. issue 4. 2021-07-29. PMID:34316424. |
this case describes a 57-year-old male with a history of severe paranoid schizophrenia despite treatment with clozapine and other psychotropic agents, who experienced clinical improvement after a cross titration from clozapine to loxapine. |
2021-07-29 |
2023-08-13 |
Not clear |
| Jennifer Erley, Sarah Goldsborough, Amy VandenBerg, Alexandra Aud. Loxapine in patient with clozapine-resistant psychosis. The mental health clinician. vol 11. issue 4. 2021-07-29. PMID:34316424. |
loxapine may be a reasonable alternative in patients with treatment-refractory schizophrenia who do not tolerate or respond to clozapine. |
2021-07-29 |
2023-08-13 |
Not clear |
| Sujatha Sanjeevi, Angela Cocoma. Mental Health Nurses' Knowledge of Clozapine. Issues in mental health nursing. vol 42. issue 3. 2021-07-28. PMID:32762588. |
clozapine, sold under the brand name clozaril, is an antipsychotic medication prescribed since the 1970s as an effective treatment for individuals with treatment resistive schizophrenia. |
2021-07-28 |
2023-08-13 |
Not clear |
| Dan-Sheng Le, Heng Su, Zheng-Luan Liao, En-Yan Y. Low-dose clozapine-related seizure: A case report and literature review. World journal of clinical cases. vol 9. issue 20. 2021-07-27. PMID:34307616. |
treatment-resistant schizophrenia is a severe form of schizophrenia characterized by poor response to at least two antipsychotic drugs and is typically treated with clozapine. |
2021-07-27 |
2023-08-13 |
Not clear |
| Arthur S Nguyen, Rebecca Grossman-Kahn, Lora Wichse. Anticipatory Clozapine Dosing After Discharge From Inpatient Treatment for the Patient With Comorbid Schizophrenia and Tobacco Use. Journal of clinical psychopharmacology. vol 40. issue 6. 2021-07-26. PMID:33065717. |
anticipatory clozapine dosing after discharge from inpatient treatment for the patient with comorbid schizophrenia and tobacco use. |
2021-07-26 |
2023-08-13 |
Not clear |
| Petros Drosos, Kolbjørn Brønnick, Inge Joa, Jan Olav Johannessen, Erik Johnsen, Rune Andreas Kroken, Helen Joy Stain, Wenche Ten Velden Hegelstad, Tor Ketil Larse. One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study. Journal of clinical psychopharmacology. vol 40. issue 6. 2021-07-26. PMID:33136922. |
international guidelines for the pharmacological treatment of schizophrenia recommend a 3-step algorithm with clozapine being the third-line antipsychotic agent. |
2021-07-26 |
2023-08-13 |
Not clear |